Access cutting-edge cerebral amyloid angiopathy treatment through this clinical trial at a research site in Glendale. Study-provided care at no cost to qualified participants.
Access cerebral amyloid angiopathy specialists in Glendale at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cerebral amyloid angiopathy treatment provided free
The purpose of this study is to assess safety, tolerability, plasma pharmacokinetics and biologic activity of a single intravenous dose of AMDX-2011P in participants with cerebral amyloid angiopathy (CAA).
Sponsor: Amydis Inc.
Check if you qualify for this cerebral amyloid angiopathy clinical trial in Glendale, CA
If you're searching for cerebral amyloid angiopathy treatment options in Glendale, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Glendale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cerebral amyloid angiopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.